Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model. - Wikidata - awgldk - TriplyDB

Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.

Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.

http://www.wikidata.org/entity/Q41454864

about

An alkali-burn injury model of corneal neovascularization in the mouse.Gossypol Acetic Acid Prevents Oxidative Stress-Induced Retinal Pigment Epithelial Necrosis by Regulating the FoxO3/Sestrin2 Pathway.Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives 4-Acetoxyphenol Prevents RPE Oxidative Stress-Induced Necrosis by Functioning as an NRF2 Stabilizer.Development of a novel in vivo corneal fibrosis model in the dog.Retinal pigment epithelial cell necroptosis in response to sodium iodate The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review)Single-cell analysis reveals IGF-1 potentiation of inhibition of the TGF-β/Smad pathway of fibrosis in human keratocytes in vitro Epigenetics and ocular diseases: from basic biology to clinical study.Current and Upcoming Therapies for Ocular Surface Chemical Injuries.Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells.Recent drug therapies for corneal neovascularization.Molecular mechanisms of suberoylanilide hydroxamic acid in the inhibition of TGF-β1-mediated canine corneal fibrosis.Glucose Can Epigenetically Alter the Gene Expression of Neurotrophic Factors in the Murine Brain Cells.

P2860

Q34181129-0326CD05-7BB4-4E08-A91B-315B0954FD55 Q35573017-C04F31BF-5DA7-4D5A-8A30-FE2CEDC37064 Q35744910-9FC3D85C-E900-419E-AB63-BFA088C3D08F Q35918499-2C60F827-515B-45AF-8AC3-0CAD52B4FCC6 Q36386152-D38544F4-9D8E-450C-A211-5AA22296CBA9 Q37164303-9540D219-EC18-4A86-9DD0-EF7537980D8F Q37269942-E6261B5A-1BD8-4AEF-94D0-194CB87333C1 Q37298896-FA3B718D-4D35-4BDC-A0EB-6383B0980553 Q38169583-E214CDD9-A992-47F0-9C31-A99BEDB1CC5D Q38819339-E79CC81D-6A2D-46A3-AD5D-730845F62AE7 Q39043636-3EEAE8CE-FFAB-4EBB-AACB-4B8DEF8419FB Q39295602-9AAA501B-A106-4B05-9B23-2A8D3E5FBE6D Q42790822-F9469879-F311-4073-99A9-A949CAEA81F2 Q50583662-BBF78D10-261A-4A8D-95E4-74EB53DEB6C4

P2860

Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.

http://www.wikidata.org/entity/Q41454864

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Inhibition of multiple pathoge ...... neal alkali-burn injury model.

@en

type

label

Inhibition of multiple pathoge ...... neal alkali-burn injury model.

@en

prefLabel

Inhibition of multiple pathoge ...... neal alkali-burn injury model.

@en

P1433

Q41454864-0614C531-7D5E-4177-8DFC-0B80A5CBB083

P1476

Q41454864-25D8F7DE-CCC5-4264-A61C-DD1252CDC517

P2093

Q41454864-139957F2-A7A8-4427-B5FC-BD1C8DEEE97B

Q41454864-24C843EC-CBC5-4930-91C6-E20874DE7910

Q41454864-50E24BC0-7FD7-4B3F-BBB4-1B2D47E123FC

Q41454864-7C32FF22-27EC-437C-8E31-D1BA5B91A510

Q41454864-92D993C9-D17C-4FD2-AB75-B71A83B8C677

Q41454864-9423AD01-742B-463F-A175-2809C53C6D58

Q41454864-9D230A58-A22A-4DF9-898C-67E55D7673E0

Q41454864-D382D0A8-8603-4DE2-A402-CE8912C564C9

P2860

Q41454864-0A8BF512-EA28-4EF5-BED2-863AE4E797D2

Q41454864-0B2B9F35-5C1F-4108-A92D-F0B3F342CD95

Q41454864-1C9C80A0-F943-4CDE-81E7-A2EE2D643509

Q41454864-22EC5193-7D4C-478D-9E0B-DEA57ABC461B

Q41454864-254B6865-C6B4-4192-87D6-36F1EA94E9D1

Q41454864-33191D14-E2DF-42FD-901A-E39A76878797

Q41454864-3788FBD7-BB52-4148-89AD-AE907AA682E4

Q41454864-392C3B06-BCAB-48CC-B346-1E2CAFA8B025

Q41454864-3F1F901C-61D8-410D-BB0B-237632E966B3

Q41454864-40E99B14-D59A-4209-B2A3-3333F66CFEFE

P304

Q41454864-80B504BE-0889-4CB2-8893-308386263353

P31

Q41454864-C4C0A964-0C5B-4330-AFEF-213FF4B9CD55

P356

Q41454864-7E2C27EE-5AFA-4F27-AAD2-AD81B44F02E2

P407

Q41454864-96D7D812-B398-4A76-9C19-03218BD3FBAA

P433

Q41454864-39B27BD0-34ED-471C-AC1F-485D14A801C1

P478

Q41454864-BDD995AE-8A5A-4E17-8476-A16D718B4430

P577

Q41454864-FBC847A4-C488-4650-BCF6-848B0038C303

P698

Q41454864-0EF09D8E-49B7-4C58-A4EA-274AA4F83A30

P932

Q41454864-64315935-5F3E-485B-8488-210C6E5A15EF

P356

P1433

Molecular Pharmaceutics

P1476

Inhibition of multiple pathoge ...... neal alkali-burn injury model.

@en

P2093

Chastain Anderson

http://www.w3.org/2001/XMLSchema#string

Hongmei Zhang

http://www.w3.org/2001/XMLSchema#string

Jakub Hanus

http://www.w3.org/2001/XMLSchema#string

Michael Dellinger

http://www.w3.org/2001/XMLSchema#string

Qinbo Zhou

http://www.w3.org/2001/XMLSchema#string

Rolf Brekken

http://www.w3.org/2001/XMLSchema#string

Shusheng Wang

http://www.w3.org/2001/XMLSchema#string

Xinyu Li

http://www.w3.org/2001/XMLSchema#string

P2860

Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

Histone deacetylase inhibitors: Potential in cancer therapy

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

Clinical development of histone deacetylase inhibitors as anticancer agents

P304

307-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP300445A

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23186311

http://www.w3.org/2001/XMLSchema#string

P932

3697033

http://www.w3.org/2001/XMLSchema#string